These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
265 related articles for article (PubMed ID: 9389688)
21. Comparison of Outcomes of Hematopoietic Cell Transplants from T-Replete Haploidentical Donors Using Post-Transplantation Cyclophosphamide with 10 of 10 HLA-A, -B, -C, -DRB1, and -DQB1 Allele-Matched Unrelated Donors and HLA-Identical Sibling Donors: A Multivariable Analysis Including Disease Risk Index. Bashey A; Zhang X; Jackson K; Brown S; Ridgeway M; Solh M; Morris LE; Holland HK; Solomon SR Biol Blood Marrow Transplant; 2016 Jan; 22(1):125-33. PubMed ID: 26359881 [TBL] [Abstract][Full Text] [Related]
22. [A pilot study of G-CSF mobilized allogeneic bone marrow cells plus peripheral blood stem cells transplantation for malignant hematological diseases]. Chen Y; Huang X; Xu L; Liu D; Zhang Y; Ren H; Guo N; Lu D Zhonghua Yi Xue Za Zhi; 2002 Oct; 82(19):1306-9. PubMed ID: 12509932 [TBL] [Abstract][Full Text] [Related]
23. Total Body Irradiation-Based Myeloablative Haploidentical Stem Cell Transplantation Is a Safe and Effective Alternative to Unrelated Donor Transplantation in Patients Without Matched Sibling Donors. Solomon SR; Sizemore CA; Sanacore M; Zhang X; Brown S; Holland HK; Morris LE; Bashey A Biol Blood Marrow Transplant; 2015 Jul; 21(7):1299-307. PubMed ID: 25797174 [TBL] [Abstract][Full Text] [Related]
24. Haploidentical hematopoietic stem cell transplantation without in vitro T-cell depletion for the treatment of hematological malignancies. Huang XJ; Liu DH; Liu KY; Xu LP; Chen H; Han W; Chen YH; Wang JZ; Gao ZY; Zhang YC; Jiang Q; Shi HX; Lu DP Bone Marrow Transplant; 2006 Aug; 38(4):291-7. PubMed ID: 16883312 [TBL] [Abstract][Full Text] [Related]
25. Allogeneic peripheral blood progenitor cell transplantation: analysis of short-term engraftment and acute GVHD incidence in 33 cases. allo-PBPCT Spanish Group. Urbano-Ispizua A; Solano C; Brunet S; Hernández F; Sanz G; Alegre A; Petit J; Besalduch J; Vivancos P; Díaz MA; Moraleda JM; Carreras E; Ojeda E; de la Rubia J; Benet I; Domingo-Albós A; García-Conde J; Rozman C Bone Marrow Transplant; 1996 Jul; 18(1):35-40. PubMed ID: 8831993 [TBL] [Abstract][Full Text] [Related]
26. Impact of donor age on outcome after allogeneic hematopoietic cell transplantation. Rezvani AR; Storer BE; Guthrie KA; Schoch HG; Maloney DG; Sandmaier BM; Storb R Biol Blood Marrow Transplant; 2015 Jan; 21(1):105-12. PubMed ID: 25278458 [TBL] [Abstract][Full Text] [Related]
27. Cotransplantation of HLA-identical sibling culture-expanded mesenchymal stem cells and hematopoietic stem cells in hematologic malignancy patients. Lazarus HM; Koc ON; Devine SM; Curtin P; Maziarz RT; Holland HK; Shpall EJ; McCarthy P; Atkinson K; Cooper BW; Gerson SL; Laughlin MJ; Loberiza FR; Moseley AB; Bacigalupo A Biol Blood Marrow Transplant; 2005 May; 11(5):389-98. PubMed ID: 15846293 [TBL] [Abstract][Full Text] [Related]
29. A Bortezomib-Based Regimen Offers Promising Survival and Graft-versus-Host Disease Prophylaxis in Myeloablative HLA-Mismatched and Unrelated Donor Transplantation: A Phase II Trial. Koreth J; Kim HT; Lange PB; Bindra B; Reynolds CG; Chammas MJ; Armand P; Cutler CS; Ho VT; Glotzbecker B; Nikiforow S; Ritz J; Blazar BR; Soiffer RJ; Antin JH; Alyea EP Biol Blood Marrow Transplant; 2015 Nov; 21(11):1907-13. PubMed ID: 26055298 [TBL] [Abstract][Full Text] [Related]
30. Comparison of outcome of allogeneic bone marrow transplantation with and without granulocyte colony-stimulating factor (lenograstim) donor-marrow priming in patients with chronic myelogenous leukemia. Ji SQ; Chen HR; Wang HX; Yan HM; Pan SP; Xun CQ Biol Blood Marrow Transplant; 2002; 8(5):261-7. PubMed ID: 12064363 [TBL] [Abstract][Full Text] [Related]
31. Biosimilar Filgrastim (Tevagrastim, XMO2) for Allogeneic Hematopoietic Stem Cell Mobilization and Transplantation in Patients with Acute Myelogenous Leukemia/Myelodysplastic Syndromes. Danylesko I; Sareli R; Bloom-Varda N; Yerushalmi R; Shem-Tov N; Shimoni A; Nagler A Biol Blood Marrow Transplant; 2016 Feb; 22(2):277-283. PubMed ID: 26343949 [TBL] [Abstract][Full Text] [Related]
32. G-CSF given after haematopoietic stem cell transplantation using HLA-identical sibling donors is associated to a higher incidence of acute GVHD II-IV. Remberger M; Naseh N; Aschan J; Barkholt L; LeBlanc K; Svennberg P; Ringdén O Bone Marrow Transplant; 2003 Jul; 32(2):217-23. PubMed ID: 12838288 [TBL] [Abstract][Full Text] [Related]
33. Comparison of the content and subpopulations of CD3 and CD34 positive cells in bone marrow harvests and G-CSF-mobilized peripheral blood leukapheresis products from healthy adult donors. Hassan HT; Stockschläder M; Schleimer B; Krüger W; Zander AR Transpl Immunol; 1996 Dec; 4(4):319-23. PubMed ID: 8972563 [TBL] [Abstract][Full Text] [Related]
34. Using related donors other than genotypically HLA-matched siblings in allogeneic hematopoietic stem cell transplantation for hematologic disease: a single institution experience in Japan. Tomonari A; Iseki T; Ooi J; Takahashi S; Ishii K; Takahashi T; Shindo M; Nagamura F; Uchimaru K; Nagayama H; Shirafuji N; Tojo A; Tani K; Asano S Int J Hematol; 2002 Nov; 76(4):354-9. PubMed ID: 12463600 [TBL] [Abstract][Full Text] [Related]
35. Allogeneic bone marrow transplantation for chronic myeloid leukemia using HLA identical sibling donors primed with G-CSF. Chen HR; Ji SQ; Wang HX; Yan HM Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2002 Aug; 10(4):340-6. PubMed ID: 12513770 [TBL] [Abstract][Full Text] [Related]
36. Unmanipulated haploidentical transplants compared with other alternative donors and matched sibling grafts. Raiola AM; Dominietto A; di Grazia C; Lamparelli T; Gualandi F; Ibatici A; Bregante S; Van Lint MT; Varaldo R; Ghiso A; Gobbi M; Carella AM; Signori A; Galaverna F; Bacigalupo A Biol Blood Marrow Transplant; 2014 Oct; 20(10):1573-9. PubMed ID: 24910379 [TBL] [Abstract][Full Text] [Related]
37. Allogeneic peripheral blood stem cell transplantation and early detection of donor engraftment by polymerase chain reaction. Tzeng CH; Lyou JY; Lin JS; Chen YR; Hu HY; Yung CH; Wang SY; Lee JC J Formos Med Assoc; 1998 Apr; 97(4):252-60. PubMed ID: 9585676 [TBL] [Abstract][Full Text] [Related]
38. Prophylactic growth factor-primed donor lymphocyte infusion using cells reserved at the time of transplantation after allogeneic peripheral blood stem cell transplantation in patients with high-risk hematologic malignancies. Sohn SK; Jung JT; Kim DH; Lee NY; Seo KW; Chae YS; Park SW; Kim JG; Suh JS; Lee KB Cancer; 2002 Jan; 94(1):18-24. PubMed ID: 11815956 [TBL] [Abstract][Full Text] [Related]
39. Allogeneic peripheral blood stem cell transplantation in patients with early-phase hematologic malignancy: a retrospective comparison of short-term outcome with bone marrow transplantation. Lemoli RM; Bandini G; Leopardi G; Rosti G; Bonini A; Fortuna A; Rondelli D; Mangianti S; Motta MR; Rizzi S; Tassi C; Cavo M; Remiddi C; Curti A; Conte R; Tura S Haematologica; 1998 Jan; 83(1):48-55. PubMed ID: 9542323 [TBL] [Abstract][Full Text] [Related]
40. Cytokine-mobilized allogeneic peripheral blood stem cell transplants in children result in rapid engraftment and a high incidence of chronic GVHD. Levine JE; Wiley J; Kletzel M; Yanik G; Hutchinson RJ; Koehler M; Neudorf S Bone Marrow Transplant; 2000 Jan; 25(1):13-8. PubMed ID: 10654008 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]